Neuropsychological Evaluation Report: Format & Writing Guide
What Is a Neuropsychological Evaluation?
A neuropsychological evaluation is a comprehensive assessment of cognitive functioning conducted by a clinical neuropsychologist. It measures performance across discrete cognitive domains — attention and processing speed, learning and memory, executive function, language, visuospatial abilities, and motor function — using a battery of standardized, norm-referenced tests. The evaluation identifies patterns of cognitive strengths and weaknesses to inform diagnosis, characterize the functional impact of brain disease or injury, guide treatment and rehabilitation planning, and establish baselines for monitoring cognitive change over time.
The neuropsychological report is distinguished from other psychological assessment reports by its emphasis on brain-behavior relationships. Rather than focusing primarily on emotional functioning or personality (as in a psychological evaluation) or academic skills (as in a psychoeducational assessment), the neuropsychological report maps the patient's cognitive profile onto what is known about neuroanatomical systems and neuropathological processes.
Neuropsychological evaluations are used across the lifespan but are particularly common in aging populations, where the differential diagnosis between normal age-related cognitive changes, mild cognitive impairment (MCI), and various dementia syndromes is a frequent referral question.
When You Need It
- Cognitive complaints in older adults — When a patient or family reports memory loss, word-finding difficulties, or functional decline that may represent MCI or early dementia versus normal aging or depression.
- Differential diagnosis of dementia subtypes — Distinguishing Alzheimer's disease from frontotemporal dementia, Lewy body dementia, vascular cognitive impairment, or other neurodegenerative conditions based on the cognitive profile.
- Traumatic brain injury — Documenting cognitive sequelae of concussion or moderate-to-severe TBI, tracking recovery, and guiding return-to-work or return-to-play decisions.
- Stroke and cerebrovascular disease — Characterizing post-stroke cognitive deficits to inform rehabilitation targets.
- Epilepsy surgery workups — Pre-surgical neuropsychological evaluation to lateralize cognitive functions and predict surgical risk.
- Psychiatric vs. neurological differentiation — Determining whether cognitive complaints reflect a primary psychiatric condition (e.g., depression-related cognitive dysfunction, "pseudodementia") versus an underlying neurodegenerative process.
- Baseline and serial assessment — Establishing cognitive baselines before chemotherapy, deep brain stimulation, or other medical procedures, and monitoring change over time.
- Forensic and disability evaluations — Documenting cognitive impairment for Social Security disability, personal injury litigation, or competency determinations.
Key Components / Required Sections
- Patient Demographics and Referral Information — Identifying data, referral source, and the specific clinical question.
- Relevant History — Medical history (with emphasis on neurological conditions, surgeries, medications), psychiatric history, developmental history, educational and occupational background, substance use, and relevant family history (particularly neurodegenerative diseases).
- Neuroimaging and Laboratory Findings — Summary of relevant MRI/CT, PET, EEG, and blood work when available. The neuropsychologist should reference these findings in the integration but not interpret them independently unless qualified to do so.
- Behavioral Observations — Mental status, effort indicators, mood and affect during testing, and observations regarding sensory or motor limitations that may affect performance.
- Performance Validity Testing — Results of embedded and stand-alone performance validity tests (PVTs). This is a critical section in neuropsychological reports and is required by NAN guidelines.
- Tests Administered — Full list of measures.
- Test Results by Cognitive Domain — Organized by domain:
- Intellectual/General Cognitive Ability
- Attention and Processing Speed
- Learning and Memory (verbal and visual)
- Executive Function
- Language
- Visuospatial/Visuoconstructional Abilities
- Motor Function (when assessed)
- Emotional/Psychological Functioning
- Neuropsychological Summary and Diagnostic Impressions — Integration of findings into a profile-level analysis, comparison with expected cognitive trajectory based on premorbid estimates, and DSM-5-TR or etiological diagnosis.
- Recommendations — Clinical management, cognitive rehabilitation, safety considerations (driving, independent living), caregiver support, and follow-up.
Example Report
Neuropsychological Evaluation Report — Cognitive Decline / Dementia Screening (Older Adult)
NEUROPSYCHOLOGICAL EVALUATION REPORT
Patient Name: R.T. Date of Birth: XX/XX/1950 Age at Evaluation: 75 years Education: 16 years (bachelor's degree in engineering) Date(s) of Evaluation: 03/03/2026, 03/04/2026 Date of Report: 03/14/2026 Evaluator: [Neuropsychologist Name], Ph.D., ABPP-CN Referral Source: Dr. [Name], Neurology
REFERRAL QUESTION
R.T. was referred by his neurologist for comprehensive neuropsychological evaluation due to a two-year history of progressive memory difficulties. His wife reports increasing forgetfulness, repetitive questions, missed appointments, and a recent incident where he became lost while driving a familiar route. His neurologist administered the MoCA in office, on which he scored 22/30. The referral questions are: (1) What is R.T.'s current cognitive profile? (2) Is the pattern consistent with a neurodegenerative process, and if so, which subtype? (3) What are the functional implications?
RELEVANT HISTORY
Medical History: Hypertension (managed with lisinopril), hyperlipidemia (atorvastatin), type 2 diabetes (metformin, HbA1c 7.1% per most recent labs). No history of head injury, stroke, or seizures. No history of general anesthesia in the past 5 years.
Neuroimaging: Brain MRI (01/2026) demonstrated bilateral hippocampal atrophy (rated moderate on visual rating scale), mild periventricular white matter hyperintensities, and no evidence of mass lesion or acute infarct.
Psychiatric History: No history of diagnosed psychiatric conditions. Denies significant depressive symptoms. PHQ-9 score of 6 (mild). GAD-7 score of 4 (minimal).
Substance Use: No current tobacco, alcohol, or illicit drug use. History of social alcohol use, discontinued approximately 10 years ago.
Family History: Mother diagnosed with Alzheimer's disease at age 72, deceased at 79. Father had cardiovascular disease, no known cognitive impairment.
Occupational/Social: Retired mechanical engineer. Lives with wife of 48 years. Previously active in community organizations; has reduced involvement over the past year. Wife now manages finances and medications, having assumed these responsibilities approximately 6 months ago.
BEHAVIORAL OBSERVATIONS AND VALIDITY
R.T. presented as a well-dressed, pleasant man who was cooperative throughout the evaluation. He was oriented to person and place but was inaccurate on the date (off by one week) and initially stated the year as 2025. He demonstrated limited awareness of his cognitive deficits, stating he was "a little forgetful, like everyone my age," while his wife provided notably more concerning examples. Effort was adequate across all tasks. Stand-alone performance validity testing (TOMM Trial 2 = 48/50) and embedded validity indicators were within acceptable limits, supporting the validity of the results.
TESTS ADMINISTERED
- Wechsler Adult Intelligence Scale–Fourth Edition (WAIS-IV) — select subtests
- Wechsler Memory Scale–Fourth Edition (WMS-IV) — select subtests
- California Verbal Learning Test–Second Edition (CVLT-II)
- Rey Complex Figure Test (RCFT) — Copy, Immediate Recall, Delayed Recall
- Delis-Kaplan Executive Function System (D-KEFS) — Trail Making, Verbal Fluency, Color-Word Interference, Sorting
- Trail Making Test (TMT) Parts A & B
- Wisconsin Card Sorting Test (WCST) — 64-card version
- Boston Naming Test–Second Edition (BNT-2)
- Controlled Oral Word Association Test (COWAT — FAS)
- Animal Fluency
- Judgment of Line Orientation (JLO)
- Grooved Pegboard — bilateral
- Geriatric Depression Scale (GDS)
- Test of Memory Malingering (TOMM)
TEST RESULTS
Premorbid Estimate: Based on demographic variables (16 years of education, professional occupation) and reading-based estimates (WTAR SS = 112), R.T.'s premorbid cognitive ability is estimated in the High Average range.
General Intellectual Ability: Current WAIS-IV performance yields a Verbal Comprehension Index of 104 (Average) and a Perceptual Reasoning Index of 98 (Average). While these scores fall within the Average range, they represent a decline from his estimated premorbid High Average baseline, particularly in perceptual reasoning.
Attention and Processing Speed: TMT-A was completed within normal limits (T = 42). WAIS-IV Digit Span was Average (SS = 9). Processing Speed Index was Low Average (PSI = 85), reflecting some slowing relative to premorbid expectations but within the range attributable to age.
Learning and Memory:
| Measure | Score | Classification |
|---|---|---|
| CVLT-II Total Learning (Trials 1–5) | T = 30 | Low |
| CVLT-II Short Delay Free Recall | T = 28 | Low |
| CVLT-II Long Delay Free Recall | T = 25 | Impaired |
| CVLT-II Recognition Discriminability | T = 30 | Low |
| WMS-IV Logical Memory I (Immediate) | SS = 5 | Low |
| WMS-IV Logical Memory II (Delayed) | SS = 3 | Impaired |
| RCFT Immediate Recall | T = 28 | Low |
| RCFT Delayed Recall | T = 25 | Impaired |
Learning and memory represent R.T.'s most significantly impaired cognitive domain. He demonstrates deficits in both verbal and visual memory, with a pattern of rapid forgetting (substantial drop from immediate to delayed recall) and poor benefit from recognition cueing. This pattern — impaired encoding and storage with minimal recognition advantage — is characteristic of a hippocampal/medial temporal lobe memory profile rather than a retrieval-based deficit.
Executive Function: TMT-B was mildly slow (T = 38). D-KEFS Color-Word Interference Inhibition condition was Low Average (SS = 6). D-KEFS Sorting total score was Average (SS = 8). WCST completed 4 of 6 categories with a mildly elevated perseverative error rate. D-KEFS Verbal Fluency letter fluency was Average (T = 44); category fluency was Low (T = 33). Mild executive difficulties are present, particularly on tasks with a timed component, but executive function is relatively preserved compared to memory.
Language: BNT-2 was mildly reduced (T = 37), with 4 errors reflecting semantic paraphasias. Spontaneous speech was fluent with occasional word-finding pauses compensated by circumlocution. Comprehension of conversational speech was intact.
Visuospatial Abilities: JLO was Average (T = 45). RCFT Copy was Average (T = 42), indicating intact visuoconstructional ability.
Motor Function: Grooved Pegboard was within normal limits bilaterally for age.
Emotional Functioning: GDS total score of 8 (mild range). R.T. endorsed items reflecting loss of interest and reduced energy, which may overlap with apathy symptoms associated with neurodegenerative disease. He did not endorse sadness, hopelessness, or suicidal ideation.
NEUROPSYCHOLOGICAL SUMMARY AND DIAGNOSTIC IMPRESSIONS
R.T. presents with a neuropsychological profile characterized by prominent learning and memory deficits in both the verbal and visual modalities, with rapid forgetting and poor recognition — a pattern most consistent with dysfunction of medial temporal lobe / hippocampal memory systems. This amnestic profile is accompanied by mild anomia and mildly reduced category fluency (semantic store access), while executive functions, visuospatial abilities, and attention are relatively preserved. The cognitive profile represents a meaningful decline from his estimated premorbid High Average baseline.
The pattern of findings — predominant amnestic impairment with a hippocampal storage-type memory profile, mild semantic language difficulties, bilateral hippocampal atrophy on MRI, progressive course over two years, and positive family history — is most consistent with a neurodegenerative process of the Alzheimer's type. The profile is not consistent with normal aging, depression-related cognitive dysfunction (his mood symptoms are mild, and the memory pattern is not retrieval-based), or frontotemporal dementia (language is only mildly affected, behavior and personality are largely preserved, and executive functions are relatively intact).
Diagnostic Impressions (DSM-5-TR):
- Major Neurocognitive Disorder, probable Alzheimer's disease etiology, without behavioral disturbance (F06.70/G30.9)
RECOMMENDATIONS
- Neurology Follow-Up: Share findings with referring neurologist for consideration of amyloid biomarker confirmation (PET or CSF) if diagnostically useful, and discussion of cholinesterase inhibitor therapy (donepezil) given the mild-to-moderate stage of impairment.
- Driving Assessment: Given the episode of disorientation while driving a familiar route and the documented visuospatial and memory deficits, a formal behind-the-wheel driving evaluation through the state's Department of Motor Vehicles or an occupational therapy driving program is recommended.
- Safety and Supervision: R.T.'s wife should continue to manage medications and finances. A home safety evaluation by an occupational therapist is recommended to address stove safety, wandering risk, and other environmental hazards as the disease progresses.
- Advance Care Planning: Encourage R.T. and his family to address legal and financial planning (power of attorney, health care proxy, advance directives) while R.T. retains the capacity to participate in these decisions.
- Caregiver Support: Refer R.T.'s wife to the Alzheimer's Association (alz.org) for caregiver support groups and community resources. Caregiver burnout is a significant risk factor in dementia care.
- Cognitive and Behavioral Strategies: External memory aids (calendar systems, pill organizers, labeled drawers) and a structured daily routine can help compensate for memory deficits and reduce confusion.
- Serial Neuropsychological Assessment: Re-evaluation in 12 to 18 months is recommended to track the trajectory of cognitive decline and reassess functional capacity and safety.
[Neuropsychologist Name], Ph.D., ABPP-CN Board Certified Clinical Neuropsychologist Licensed Psychologist, [License #]
This is a sample for educational purposes only — not real patient data.
How to Write It Step by Step
Step 1: Obtain and Review Records Before Testing. Request neuroimaging reports, neurology notes, prior cognitive testing, medication lists, and relevant lab work. Reviewing these before the evaluation allows you to tailor your battery and formulate preliminary hypotheses.
Step 2: Conduct a Thorough Clinical Interview. Spend adequate time with both the patient and an informant (spouse, adult child). Discrepancies between patient self-report and informant report are diagnostically valuable — reduced awareness of deficits is itself a clinical finding common in Alzheimer's disease.
Step 3: Administer Performance Validity Tests. NAN position papers emphasize that performance validity testing is a mandatory component of neuropsychological evaluation. Include at least one stand-alone PVT (e.g., TOMM, WMT, MSVT) and attend to embedded validity indicators. Invalid effort renders the entire battery uninterpretable.
Step 4: Organize a Domain-Based Battery. Select tests that cover attention/processing speed, learning and memory (verbal and visual), executive function, language, and visuospatial abilities at minimum. Choose measures with well-established norms for your patient's demographic group. For older adults, ensure you have age-appropriate norms that extend to the patient's age range.
Step 5: Score with Demographically Corrected Norms. Use age-, education-, and sex-corrected normative data when available. Report T-scores, scaled scores, or standard scores with their normative reference. Specify which normative dataset was used.
Step 6: Interpret at the Profile Level. Neuropsychological interpretation goes beyond identifying which scores are low. Analyze the pattern of strengths and weaknesses across domains. Ask: Is the profile consistent with a known neuropsychological syndrome? Does the memory pattern reflect encoding/storage failure (hippocampal) or retrieval failure (subcortical/frontal)? Do the deficits cluster in a lateralized or diffuse pattern?
Step 7: Integrate Neuroimaging and Medical Data. When MRI, PET, or laboratory findings are available, discuss whether the neuropsychological profile is concordant with the neuroimaging pattern. Concordance strengthens diagnostic confidence; discordance should be explained.
Step 8: Address Functional Implications Explicitly. The referral source and family want to know what the scores mean for daily life. Translate cognitive test results into functional language: Can the patient manage medications independently? Is driving safe? Can they live alone? Should financial management be transferred?
Common Mistakes
- Omitting performance validity testing. Without PVTs, the clinician cannot assert that the test results are valid. This is particularly important in forensic, disability, and medicolegal contexts, but it applies to all neuropsychological evaluations.
- Using a fixed battery without adaptation. While fixed batteries (e.g., Halstead-Reitan) have historical value, most contemporary practice favors a flexible battery approach tailored to the referral question. A patient referred for dementia screening does not need the same battery as a patient referred for concussion follow-up.
- Failing to estimate premorbid function. Test scores must be interpreted relative to where the patient was before illness or injury. A current FSIQ of 100 in a retired engineer with 16 years of education likely represents decline. Report premorbid estimates using demographic formulas or reading-based measures.
- Listing scores without interpretation. A table of T-scores is not useful to the referring neurologist or family without interpretive context. Explain what each domain's performance means in terms of brain function and daily life impact.
- Neglecting emotional and psychiatric factors. Depression, anxiety, poor sleep, and medication side effects all influence cognitive test performance. Failing to screen for these factors can lead to misattribution of psychiatric cognitive effects to a neurodegenerative process.
- Writing an excessively long report. Neuropsychological reports are notorious for excessive length. Aim for thoroughness without redundancy. The referring provider should be able to find the diagnosis and key functional recommendations within the first or last page.
- Ignoring the informant. In dementia evaluations, the informant interview is often more diagnostically valuable than the patient interview, as patients with anosognosia will underreport symptoms. Always interview a knowledgeable informant.
Writing a assessment report right now?
My Clinical Writer helps you draft assessment reports from your session details in under 60 seconds.
Try My Clinical Writer Free →myclinicalwriter.ai
Frequently Asked Questions
Related Templates
External Resources
Authoritative references and tools related to this documentation type.
Stop spending hours on documentation
My Clinical Writer uses AI to help you draft clinical notes, treatment plans, and reports in minutes — not hours.
Get Started at myclinicalwriter.ai →